Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 6:43 PM View:  | Revance Therapeutics, Inc. (RVNC) | 15-Mar-24 | Payment of Exercise | 20,533 | $5.30 | $108,928.00 | (2%) 1.13M to 1.11M | |
| 08-Mar-24 4:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 06-Mar-24 | Private Purchase | 30,000 | $6.98 | $209,400.00 | 3% 1.1M to 1.13M | |
| 04-Mar-24 4:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Feb-24 | Grant | 70,750 | -- | -- | 7% 1.03M to 1.1M | |
| 26-Feb-24 7:01 PM View: | Glaukos Corp (GKOS) | 23-Feb-24 | Option Exercise | 10,000 | $7.28 | $72,750.00 | 36% 27.78K to 37.78K | |
| 26-Feb-24 7:01 PM View: | Glaukos Corp (GKOS) | 23-Feb-24 | Option Sale | 4,560 | $92.87 | $423,487.00 | (12%) 37.78K to 33.22K | |
| 03-Jan-24 4:47 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-23 | Grant | 264 | $7.47 | $1,972.08 | < 1% 1.03M to 1.03M | |
| 15-Aug-23 4:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Grant | 122,143 | -- | -- | 13% 951.29K to 1.07M | |
| 15-Aug-23 4:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 11-Aug-23 | Payment of Exercise | 48,064 | $18.91 | $908,890.00 | (4%) 1.07M to 1.03M | |
| 04-Aug-23 5:07 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-Aug-23 | Private Sale (Planned) | 26,279 | $22.57 | $593,151.00 | (3%) 977.57K to 951.29K | |
| 05-Jul-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-Jul-23 | Private Sale (Planned) | 26,279 | $24.94 | $655,333.00 | (3%) 1.0M to 977.57K | |
| 05-Jul-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-23 | Grant | 1,000 | $15.61 | $15,606.00 | < 1% 1.0M to 1.0M | (1%) |
| 13-Jun-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Jun-23 | Private Sale (Planned) | 31,279 | $30.72 | $960,928.00 | (3%) 1.03M to 1.0M | |
| 05-Jun-23 8:14 PM View: | Glaukos Corp (GKOS) | 01-Jun-23 | Grant | 3,230 | -- | -- | 13% 24.55K to 27.78K | |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-May-23 | Sale | 70,447 | $34.55 | $2,433,730.00 | (6%) 1.1M to 1.03M | |
| 17-Mar-23 3:22 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-23 | Payment of Exercise | 5,341 | $30.65 | $163,702.00 | (< 1%) 934.26K to 928.92K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-Mar-23 | Sale | 70,390 | $31.59 | $2,223,360.00 | (7%) 1.0M to 934.26K | |
| 04-Jan-23 5:58 PM View: | Glaukos Corp (GKOS) | 03-Jan-23 | Grant | 2,948 | -- | -- | 14% 21.6K to 24.55K | |
| 03-Jan-23 4:28 PM View: | Revance Therapeutics, Inc. (RVNC) | 31-Dec-22 | Grant | 605 | $12.18 | $7,369.20 | < 1% 828.4K to 829.0K | |
| 14-Oct-22 7:02 PM View: | Revance Therapeutics, Inc. (RVNC) | 13-Oct-22 | Payment of Exercise | 49,274 | $26.97 | $1,328,920.00 | (6%) 877.67K to 828.4K | |
| 09-Mar-23 10:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 22-Sep-22 | Grant | 175,649 | -- | -- | 21% 829.0K to 1.0M | |
| 05-Jul-22 6:15 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-22 | Grant | 1,000 | $11.75 | $11,747.00 | < 1% 876.67K to 877.67K | |
| 06-Jun-22 7:55 PM View: | Glaukos Corp (GKOS) | 02-Jun-22 | Grant | 4,364 | -- | -- | 25% 17.24K to 21.6K | |
| 17-Mar-22 5:54 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Mar-22 | Payment of Exercise | 3,304 | $15.79 | $52,170.20 | (< 1%) 879.98K to 876.67K | 2% |
| 16-May-23 8:29 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-22 | Grant | 175,649 | -- | -- | 19% 928.92K to 1.1M | |
| 05-Jan-22 8:55 PM View: | Glaukos Corp (GKOS) | 03-Jan-22 | Grant | 2,486 | -- | -- | 17% 14.75K to 17.24K | |
| 29-Nov-21 9:24 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Nov-21 | Market Purchase | 40,000 | $12.90 | $515,924.00 | 5% 839.98K to 879.98K | (< 1%) |
| 15-Oct-21 8:00 PM View: | Revance Therapeutics, Inc. (RVNC) | 13-Oct-21 | Payment of Exercise | 42,096 | $23.08 | $971,576.00 | (5%) 882.07K to 839.98K | 2% |
| 02-Jul-21 7:52 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Jun-21 | Acquisition (other) | 882 | $24.09 | $21,246.50 | < 1% 881.19K to 882.07K | |
| 07-Jun-21 7:04 PM View: | Glaukos Corp (GKOS) | 03-Jun-21 | Grant | 2,382 | -- | -- | 19% 12.37K to 14.75K | |
| 04-Feb-21 9:10 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-21 | Grant | 40,715 | -- | -- | 5% 840.48K to 881.19K | |
| 06-Jan-21 9:30 PM View: | Glaukos Corp (GKOS) | 04-Jan-21 | Grant | 1,184 | -- | -- | 11% 11.19K to 12.37K | |
| 15-Oct-20 6:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 13-Oct-20 | Payment of Exercise | 66,106 | $27.62 | $1,825,850.00 | (7%) 906.58K to 840.48K | < 1% |
| 02-Oct-20 8:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Grant | 301,000 | -- | -- | 69% 433.5K to 734.5K | |
| 02-Oct-20 8:33 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Sep-20 | Payment of Exercise | 143,269 | $25.14 | $3,601,780.00 | (20%) 734.5K to 591.23K | (10%) |
| 15-Oct-20 6:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jul-20 | Grant | 264,439 | -- | -- | 45% 591.23K to 855.67K | |
| 15-Oct-20 6:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jul-20 | Grant | 50,913 | -- | -- | 6% 855.67K to 906.58K | |
| 18-Jun-20 7:10 PM View: | Si-Bone, Inc. (SIBN) | 16-Jun-20 | Grant | 8,797 | -- | -- | 100% 0 to 8.8K | |
| 05-Jun-20 9:51 PM View: | Glaukos Corp (GKOS) | 03-Jun-20 | Grant | 3,900 | -- | -- | 54% 7.29K to 11.19K | |
| 24-Jan-20 8:22 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jan-20 | Grant | 200,000 | -- | -- | 94% 213.5K to 413.5K | |
| 15-Oct-19 8:23 PM View: | Revance Therapeutics, Inc. (RVNC) | 13-Oct-19 | Grant | 200,000 | -- | -- | 597% 33.5K to 233.5K | |
| 31-May-19 8:06 PM View: | Glaukos Corp (GKOS) | 30-May-19 | Grant | 2,653 | -- | -- | 57% 4.63K to 7.29K | |
| 10-May-19 8:52 PM View: | Revance Therapeutics, Inc. (RVNC) | 09-May-19 | Grant | 4,500 | -- | -- | 16% 29.0K to 33.5K | |
| 01-Jun-18 4:35 PM View: | Glaukos Corp (GKOS) | 31-May-18 | Grant | 4,633 | -- | -- | 100% 0 to 4.63K | |
| 11-May-18 8:26 PM View: | Revance Therapeutics, Inc. (RVNC) | 10-May-18 | Grant | 3,000 | -- | -- | 12% 26.0K to 29.0K | |
| 09-Nov-17 7:47 PM View: | Revance Therapeutics, Inc. (RVNC) | 07-Nov-17 | Market Purchase | 20,000 | $26.96 | $539,168.00 | 333% 6.0K to 26.0K | 2% |
| 07-Sep-17 8:44 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-Sep-17 | Grant | 6,000 | -- | -- | 100% 0 to 6.0K | |
| 28-Apr-17 1:28 PM View: | ZELTIQ Aesthetics, Inc. (ZLTQ) | 28-Apr-17 | Disposition | 173,787 | -- | -- | (100%) 173.79K to 0 | |
| 12-Apr-17 11:27 AM View: | ZELTIQ Aesthetics, Inc. (ZLTQ) | 07-Apr-17 | Gift | 37,667 | -- | -- | (18%) 211.45K to 173.79K | |
| 14-Mar-17 10:59 AM View: | ZELTIQ Aesthetics, Inc. (ZLTQ) | 13-Mar-17 | Gift | 8,976 | -- | -- | (4%) 230.43K to 221.45K | |
| 14-Mar-17 10:59 AM View: | ZELTIQ Aesthetics, Inc. (ZLTQ) | 13-Mar-17 | Market Sale (Planned) | 10,000 | $55.77 | $557,659.00 | (5%) 221.45K to 211.45K |